Literature DB >> 18806307

Effects of Coenzyme Q10 on TNF-alpha secretion in human and murine monocytic cell lines.

Constance Schmelzer1, Gerti Lorenz, Inka Lindner, Gerald Rimbach, Petra Niklowitz, Thomas Menke, Frank Döring.   

Abstract

Studies in humans and cell culture as well as bioinformatics suggested that Coenzyme Q(10) (CoQ10) functions as an anti-inflammatory molecule. Here we studied the influence of CoQ10 (Kaneka Q10) on secretion of the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) by using the human and murine monocytic cell lines THP-1 and RAW264.7 expressing human apolipoprotein E3 (apoE3) or pro-inflammatory apoE4. Incubation of cells with physiological (0.1-10 microM) and supra-physiological (> 10 to < 100 microM) concentrations of CoQ10 led to an intracellular accumulation of its reduced form without any cytotoxic effects. Stimulation of cell models with lipopolysaccharide (LPS) resulted in a substantially release of TNF-alpha. When THP-1 cells were pre-incubated with 10 microM CoQ10, the LPS-induced TNF-alpha release was significantly decreased to 72 +/- 32%. This effect is similar to those obtained by 10 microM N-Acetyl-Cysteine, a well known reference antioxidant. In RAW264.7-apoE3 and -apoE4 cells, significant reductions of LPS-induced TNF-alpha secretion to 73.3 +/- 2.8% and 74.7 +/- 8.9% were found with 2.5 microM and 75 microM CoQ10, respectively. In conclusion, CoQ10 has moderate anti-inflammatory effects in two monocytic cell lines which could be mediated by its antioxidant activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18806307     DOI: 10.1002/biof.5520310104

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  8 in total

1.  Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.

Authors:  Marianna Sikorska; Patricia Lanthier; Harvey Miller; Melissa Beyers; Caroline Sodja; Bogdan Zurakowski; Sandhya Gangaraju; Siyaram Pandey; Jagdeep K Sandhu
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

2.  Ubiquinol decreases monocytic expression and DNA methylation of the pro-inflammatory chemokine ligand 2 gene in humans.

Authors:  Alexandra Fischer; Simone Onur; Constance Schmelzer; Frank Döring
Journal:  BMC Res Notes       Date:  2012-10-01

3.  Association between genetic variants in the Coenzyme Q10 metabolism and Coenzyme Q10 status in humans.

Authors:  Alexandra Fischer; Constance Schmelzer; Gerald Rimbach; Petra Niklowitz; Thomas Menke; Frank Döring
Journal:  BMC Res Notes       Date:  2011-07-21

4.  Effects of ubiquinol-10 on microRNA-146a expression in vitro and in vivo.

Authors:  Constance Schmelzer; Mitsuaki Kitano; Gerald Rimbach; Petra Niklowitz; Thomas Menke; Kazunori Hosoe; Frank Döring
Journal:  Mediators Inflamm       Date:  2009-04-16       Impact factor: 4.711

5.  Ubiquinol reduces gamma glutamyltransferase as a marker of oxidative stress in humans.

Authors:  Simone Onur; Petra Niklowitz; Gunnar Jacobs; Ute Nöthlings; Wolfgang Lieb; Thomas Menke; Frank Döring
Journal:  BMC Res Notes       Date:  2014-07-04

6.  Coenzyme Q regulates the expression of essential genes of the pathogen- and xenobiotic-associated defense pathway in C. elegans.

Authors:  Alexandra Fischer; Petra Niklowitz; Thomas Menke; Frank Döring
Journal:  J Clin Biochem Nutr       Date:  2015-08-29       Impact factor: 3.114

Review 7.  Ubisol-Q10, a Nanomicellar and Water-Dispersible Formulation of Coenzyme-Q10 as a Potential Treatment for Alzheimer's and Parkinson's Disease.

Authors:  Darcy Wear; Caleb Vegh; Jagdeep K Sandhu; Marianna Sikorska; Jerome Cohen; Siyaram Pandey
Journal:  Antioxidants (Basel)       Date:  2021-05-11

Review 8.  Effect of Coenzyme Q10 Supplementation on Serum of High Sensitivity c-reactive Protein Level in Patients with Cardiovascular Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Zahra Aslani; Sakineh Shab-Bidar; Somaye Fatahi; Kurosh Djafarian
Journal:  Int J Prev Med       Date:  2018-09-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.